J&J | JNJ - Przychody Ze Sprzedaży

Cena Akcji
227.33
Dzienna Zmiana
-0.46 -0.20%
Miesięcznie
-6.25%
Rocznie
45.44%
Q2 Prognozy TE
222.63




Obroty Zmiana Data
AbbVie USD 15B 1.62B 2026-03
Abbott USD 11.16B 300M 2026-03
Amgen USD 9.9B 340M 2025-12
AstraZeneca USD 15.29B 213M 2026-03
Baxter International USD 2.97B 130M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Biogen USD 2.25B 30M 2026-03
Boston Scientific USD 5.2B 90M 2026-03
Bristol-Myers Squibb USD 12.5B 300M 2025-12
CONMED USD 317M 56.2M 2026-03
Cooper Companies USD 1.02B 41.1M 2025-12
Dexcom USD 1.26B 50M 2025-12
Edwards Lifesciences USD 1.65B 80M 2026-03
Eli Lilly USD 19.3B 1.7B 2025-12
Gilead Sciences USD 7.93B 130M 2025-12
GlaxoSmithKline GBP 7.63B 991M 2026-03
Globus Medical USD 826.4M 57.4M 2025-12
Insulet USD 783.8M 77.5M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.77B 100M 2026-03
J&J USD 24.1B 500M 2026-03
Medtronic USD 9B 39M 2026-01
Merck USD 16.4B 880M 2025-12
Merit Medical Systems USD 393.9M 9.7M 2025-12
Novartis USD 13.11B 226M 2026-03
Pfizer USD 17.58B 880M 2025-12
Regeneron Pharmaceuticals USD 3.6B 280M 2026-03
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.24B 60M 2026-03
Stryker USD 7.2B 1.14B 2025-12
Tandem Diabetes Care USD 290.4M 41.15M 2025-12
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
Vertex Pharmaceuticals USD 3.19B 110M 2025-12
Zimmer Biomet Holdings USD 2.09B 150M 2026-03
Zoetis USD 2.4B 0 2025-12